{
    "Relevant Biomarkers": [
        {
            "BioMarker": "BRCA2",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Mutation not detected"
        },
        {
            "BioMarker": "TOP2A",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Mutation not detected"
        },
        {
            "BioMarker": "NTRK1",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Mutation not detected"
        },
        {
            "BioMarker": "MAPK1",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Fusion not detected"
        },
        {
            "BioMarker": "ER",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Positive| 2+, 5%"
        },
        {
            "BioMarker": "AR",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Positive| 1+, 74%"
        },
        {
            "BioMarker": "Mismatch repair status",
            "Method": "IHC",
            "Analyte": "Protien",
            "Result": "Positive| 1+, 16%"
        },
        {
            "BioMarker": "ARID2",
            "Method": "Seq",
            "Analyte": "RNA-Tumor",
            "Result": "Fusion not detected"
        },
        {
            "BioMarker": "STAT5B",
            "Method": "Seq",
            "Analyte": "DNA-Tumor",
            "Result": "Stable"
        }
    ],
    "Genomic Signatures": [
        {
            "BioMarker": "Microsatellite instability",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "Equivocal"
        },
        {
            "BioMarker": "Tumor mutational burden",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "13 mutations/Mb High"
        },
        {
            "BioMarker": "Genomic loss of heterozygosity (LOH)",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Result": "High - 33% of tested genmoic segments exhibit LOH"
        }
    ],
    "Genes Tested with Pathogenic Alterations": [
        {
            "Gene": "FLT3",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Benign",
            "Protien Alteration": "p.G12D",
            "Exon": 13,
            "DNA Alteration": "c.35G>T",
            "Allele Frequency %": "28.22"
        },
        {
            "Gene": "PTCH1",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Pathogenic",
            "Protien Alteration": "p.K656E",
            "Exon": 19,
            "DNA Alteration": "c.1966A>G",
            "Allele Frequency %": "17.97"
        },
        {
            "Gene": "MAP2K2",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Pathogenic",
            "Protien Alteration": "p.S249C",
            "Exon": 13,
            "DNA Alteration": "c.1948A>G",
            "Allele Frequency %": "2.2"
        },
        {
            "Gene": "RB1",
            "Method": "Seq",
            "Analyte": "DNA tumor",
            "Variant Interpretation": "Likely Benign",
            "Protien Alteration": "p.K656E",
            "Exon": 19,
            "DNA Alteration": "c.1966A>G",
            "Allele Frequency %": "6.39"
        }
    ]
}